Religare Enterp. (RELIGARE)

FairStock Score: 13/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Low debt-to-equity of 0.08 provides balance sheet resilience.
• Sales growth of 23.25% shows the underlying business is expanding.
• Positive ROCE of 8.39% suggests some operating assets still generate returns.
• No immediate solvency pressure from high leverage.

Concerns

• Latest quarter net loss of ₹77 Cr and ROE of -1.85% indicate shareholder value destruction.
• P/E of 68.61 and P/B of 3.48 are rich for a company currently earning negative profits.
• Piotroski F-Score of 4/9 points to weak fundamental health.
• No dividend yield and promoter holding of 26.27% reduce minority investor comfort.

AI Analysis

At ₹221.79, Religare commands a market cap of ₹7,053 Cr while book value is only ₹63.75 per share. That is a price-to-book of 3.48 for a business earning a negative ROE of -1.85%. As Graham would say, price is what you pay, value is what you get. Here, I am asked to pay a large premium for an investment company that just reported a ₹77 Cr net loss in the latest quarter. The 68.61 P/E is not a sign of quality; it is a reminder that earnings have nearly disappeared. Sales growth of 23.25% looks encouraging, but profit growth is -5.32%, and the Piotroski F-Score of 4/9 tells me fundamentals are deteriorating, not improving. I do respect the balance sheet: debt-to-equity of 0.08 means the company is not drowning in leverage, and ROCE of 8.39% suggests some operational assets still generate returns. But no dividend and zero yield mean I cannot wait indefinitely for a recovery. With promoter holding only 26.27%, I would want strong, aligned insiders before trusting a turnaround story. In Buffett's language, this is not a wonderful business at a fair price; it is a potentially ordinary business at an expensive price. For a retail investor, the risk of permanent capital loss is high. The 52-week range shows the stock has fallen from ₹284.85 to ₹221.79, yet it still is not cheap. I need evidence of meaningful improvement in return on equity, sustained profits, and disciplined capital allocation before I would consider this a serious value candidate. Today it is a speculative turnaround, not an investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer